Literature DB >> 6837600

Effects of blood transfusion on exercise capacity in patients with sickle-cell anemia.

S Charache, E R Bleecker, D S Bross.   

Abstract

Although sickle cells have increased intracellular viscosity, the viscosity of patient's blood is usually not increased, because of the low hematocrit typically found in such patients. When patients receive transfusions, their exercise capacity increases, but it is unclear whether the change is due primarily to increased hemoglobin concentration, or also reflects improved flow properties of the blood due to dilution of sickle cells with normal erythrocytes. To evaluate the relative importance of these two factors, submaximal exercise studies were performed before and after a series of transfusions. Exercise capacity improved and the patients were able to perform increased amounts of work at lower heart rates. Regression analyses indicated that the percent of sickle cells in patient's blood did not have a significant effect on exercise capacity after the transfusion-induced increase in hemoglobin concentration was taken into account. At the hematocrits typically found in patients, altered viscosity of blood due to the presence of sickle cells is much less important than hemoglobin concentration as a determinant of exercise capacity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837600     DOI: 10.1016/0002-9343(83)91063-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Adedoyin Dosunmu; Adewumi Adediran; Olajumoke Oshinaike; Adebola Phillip; Osunkalu Vincent; Arogundade Olanrewaju; Adelekan Oluwaseun
Journal:  Caspian J Intern Med       Date:  2012

2.  Hemodynamic response to exercise in patients with sickle cell anemia.

Authors:  M E McConnell; S R Daniels; J Lobel; F W James; S Kaplan
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

3.  Cardiovascular effects of hypertransfusion therapy in children with sickle cell anemia.

Authors:  L A Lester; P C Sodt; N Hutcheon; R A Arcilla
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

4.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

5.  Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with sickle cell anemia.

Authors:  Robert I Liem; Madhuri Reddy; Stephanie A Pelligra; Adrienne P Savant; Bo Fernhall; Mark Rodeghier; Alexis A Thompson
Journal:  Physiol Rep       Date:  2015-04

6.  Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria.

Authors:  Akinsegun A Akinbami; Adedoyin O Dosunmu; Adewumi A Adediran; Olajumoke O Oshinaike; Vincent O Osunkalu; Sarah O Ajibola; Olanrewaju M Arogundade
Journal:  J Blood Med       Date:  2013-05-22

7.  The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Ryad Tamouza; Gama P Le Bouder; Ramita Dewan; Naomi L C Luban; Jacqueline Lasserre; Jacqueline Maury; François Lionnet; Rajagopal Krishnamoorthy; Robert Girot; Stanislav Vukmanovic
Journal:  Clin Dev Immunol       Date:  2013-05-22

8.  Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia.

Authors:  Xavier Waltz; Marc Romana; Marie-Dominique Hardy-Dessources; Yann Lamarre; Lydia Divialle-Doumdo; Marie Petras; Vanessa Tarer; Régine Hierso; Kizzy-Clara Baltyde; Benoît Tressières; Marie-Laure Lalanne-Mistrih; Fréderic Maillard; Olivier Hue; Maryse Etienne-Julan; Philippe Connes
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell disease.

Authors:  Jenelle A Noble; Kimberley C Duru; Aldiouma Guindo; Li Yi; Ikhide G Imumorin; Dapa A Diallo; Bolaji N Thomas
Journal:  PeerJ       Date:  2015-02-24       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.